Your session is about to expire
← Back to Search
Anti-infective
Intranasal Povidone Iodine for Asymptomatic Colonization
Phase 4
Recruiting
Led By Mary K. Hayden, MD
Research Sponsored by Mary K Hayden
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
History of C. auris colonization or infection
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion and data analysis in three years (2028)
Awards & highlights
Study Summary
This trial will test whether using a specific type of antiseptic in the nose can help in detecting a type of fungus called Candida auris.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had a C. auris infection or been colonized by it.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion and data analysis in three years (2028)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion and data analysis in three years (2028)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Detection of C. auris from the anterior nares
Secondary outcome measures
Detection of C. auris from body sites other than anterior nares
Detection of C. auris from environmental surfaces
Detection of MRSA from environmental surfaces
+1 moreOther outcome measures
Change in microbiome community
Non-susceptibility of C. auris to povidone iodine
Trial Design
2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Routine care.
Group II: Intranasal Povidone IodineActive Control1 Intervention
Nasal iodophor applied twice daily for five days.
Find a Location
Who is running the clinical trial?
Mary K HaydenLead Sponsor
Rush University Medical CenterOTHER
424 Previous Clinical Trials
156,615 Total Patients Enrolled
RML Specialty HospitalOTHER
4 Previous Clinical Trials
811 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger